- Dr Lovorka Đerek and her team evaluated a range of tests, including ANA screening, anti-dsDNA, anti-cardiolipin IgG and IgM, anti-B2GPI IgG and IgM, anti-tTG IgA and anti-DGP, anti-MPO and anti-PR3.
- The CVs obtained for each marker met all the internal criteria as well as those stated by Sebia.
- They highlighted the user-friendly software, as well as the flexibility of the random access automation.
- Not having to batch samples, combined with the small footprint of the instrument, was found to be very practical.
Tests associated with this resource
Related instrument
Any assay, any sample, any time!
This section contains information intended for wide distribution and may therefore contain product details or information that is not available or valid in your country. Please contact your local Sebia representative. Information intended for healthcare professionals. Carefully read the instructions in the reagent package inserts and instrument manuals.